Related Experiment Video
Updated: Nov 13, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
A systematic review of clinical and laboratory parameters associated with increased severity among COVID-19 patients
Asmita A Mehta1, Nithya Haridas1, Preeti Belgundi2
1Department of Respiratory Medicine, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeethem, Ponekara, Kochi-682041, Kerala, India.
Insights
This systematic review identifies clinical and laboratory indicators of severe COVID-19. Key findings include older age, male sex, and dyspnea as risk factors, alongside specific lab abnormalities like lymphopenia and elevated D-dimer.
Area of Science:
- Infectious Diseases
- Epidemiology
- Clinical Medicine
Background:
- The COVID-19 pandemic has presented significant global health challenges.
- Understanding factors associated with disease severity is crucial for patient management.
Purpose of the Study:
- To systematically review and summarize clinical and laboratory parameters indicative of increased severity in COVID-19 patients.
Main Methods:
- A comprehensive literature search was conducted to identify high-quality research articles.
- Data on epidemiology, demographics, clinical presentation, and outcomes were evaluated.
Main Results:
- Severe COVID-19 was associated with a higher mean age (59.3 years) and male sex.
- Clinical indicators of severity included dyspnea. Laboratory markers included lymphopenia, thrombocytopenia, leucocytosis, elevated procalcitonin, D-dimer, AST, and LDH.
Conclusions:
- COVID-19 exhibits varied clinical and laboratory presentations.
- Lymphopenia, elevated LDH, D-dimer, and procalcitonin are key laboratory indicators of severe disease.
Background And Aims:
Corona virus disease 2019 (COVID-19) has been an extremely difficult pandemic to contain and it has affected more than 148 countries worldwide. The main aim of this systematic review is to provide a comprehensive summary of clinical and laboratory parameters that are associated with and indicative of increased severity among COVID-19 patients.
Material And Methods:
All the available data from high-quality research articles relevant to the epidemiology, demographics, trends in hospitalization and outcomes, clinical signs and symptoms, diagnostic methods and treatment methods of COVID-19 were retrieved and evaluated for inclusion.
Results:
As per our review, the mean age of patients in the severe group was 59.3 years compared to 46.5 years in non severe group. COVID-19 was more severe among men than women. Clinical presentation was variable among different studies. and dyspnea was the factor indicating severe disease. Laboratory parameters associated with increased severity were lymphopenia <0.8 × 109/L, thrombocytopenia 100 × 109/L, leucocytosis TC > 11 × 109/L, procalcitonin >0.5 ng/mL, d dimer >2 mcg/mL, aspartate transaminase elevation >150U/L, LDH >250U/L.
Conclusion:
This systematic review suggests that COVID-19 is a disease with varied clinical presentation and laboratory parameters. The commonest clinical symptoms were fever, cough and dyspnea. The laboratory parameters associated with severe disease were lymphopenia, elevated LDH, D dimer and Procalcitonin.
More Related Videos
06:29Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia III: Complications and Assessment
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome III: Diagnostic Studies